NEWS

Global
There's Need to Set Time Frame for Hunger, Poverty Eradication; FAO Director General Claims 
Lebanon to Become 165th Party to CPB 

Africa
1st Bio-Innovate Regional Scientific Conference in Ethiopia 

Americas
Food Science Expert Says GM Crops are Overregulated 
Oregon State University Develops High Yielding, Stripe Rust Resistant Wheat 
Paraguay Approves New Biotech Soybean Variety 
Genetic Diversity of Capsicum Peppers Revealed 
CIMMYT Inaugurates Biosciences Facilities in Mexico 

Asia and the Pacific
Philippine Rice Research in the Spotlight as the Country's President Visits IRRI 
CIMMYT Launches Project to Develop Heat Resilient Maize for South Asia 
India's Agriculture Minister Supports Field Trials of GM Crops 
CropLife Pakistan Forms Biotech Committee 

Europe
Scientists Call for New Regulations for "Growing" Medicines in Plants 
Britain's Egg Producers Call to Lift GM Ban 
Scientists Develop Healthier Barley 

Research
Impact of the ahas Gene and of Imazapyr Herbicide on Soil Microbial Communities 
Researchers Confirm Bt Corn's Benefits Aside from Pest Resistance 

Announcements
ISAAA International Conference: Adoption of Biotech Crops in the Developing World 
National Symposium on Abiotic and Biotic Stress Management in Vegetable Crops 

Document Reminders
Proceedings on Agribiotech Communication in Muslim Countries 
Book: Successful Agricultural Innovation in Emerging Economies 

Scientists Call for New Regulations for "Growing" Medicines in Plants

Scientists from the US and Europe are recommending for amendments in an EU directive on GMOs to help stimulate innovation in making cheaper vaccines, pharmaceuticals, and organic plastics using plants. They published a paper in Current Pharmaceutical Design, comparing the risk assessment and regulation between US and Europe. They reported that in EU, plant-made pharmaceuticals need authorization similar with GM crops. In theory, agricultural crops can be grown by any farmer in EU once approved. However, this is not the case for pharmaceutical crops. Drug companies would likely license farmers to these crops under controlled, defined, and confined conditions.

Penny Sparrow of the John Innes Centre suggests that openness and transparency are vital to come up with new regulations that work for the public as well as for investors. Plant molecular farming will help in massive production of low-cost therapeutic proteins. This could benefit developing countries where storage concerns often lead to useless vaccines.

Read more details at http://news.jic.ac.uk/2013/02/growing-medicines-in-plants-requires-new-regulations/.


Share    

This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)

Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS

Article Search: